Dr. Abbey to Speak at Upcoming Retina World Congress Medical Education Event
On October 24, 2021, Texas Retina Associates’ Ashkan M. Abbey, MD, will serve on a distinguished panel of presenters from across the country for a Retina World Congress continuing medical education (CME)
read more
New Clinical Trials Available
Medical researchers continue to discover new sight-saving treatments for retinal diseases that once robbed patients of their vision. At Texas Retina Associates, we are currently participating in more than 20 clinical trials
read more
New Clinical Trials Enrolling in Plano
At Texas Retina Associates, we remain committed to examining new options that are ethical, based on a solid science platform and provide minimal risks to our patients. Our Plano research team is
read more
New Clinical Trials Offer Patients Access to Promising New Retina Treatments
At Texas Retina Associates, we remain committed to safely providing our patients with compassionate and personalized retina care, including access to breakthrough, sight-saving treatments through clinical trials. In fact, our physicians have
read more Texas Retina Associates Participating in Pagoda Clinical Trial for Diabetic Macular Edema
Sponsored by Genentech, the Pagoda clinical trial is studying an investigational drug delivery system for diabetic macular edema (DME) treatment to see if it could result in fewer eye injections and eye
read more
Getting to Know Michel J. Shami, MD
With more than 30 years of experience, retina specialist Michel J. Shami, MD, has served Texas Retina Associates since 2001, and sees patients in our Lubbock office. Dr. Shami is an active
read more
Clinical Trials Help Uncover New Sight-Saving Treatment Options
At Texas Retina Associates, our physicians are committed to continually improving care for our patients, and a big part of that involves conducting ongoing research of potential new sight-saving retina treatments. Clinical
read more